Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoantibodies to factor VIII.

Sébastien Lacroix-Desmazes1, Namita Misra, Jagadeesh Bayry

  • 1INSERM U430, Hôpital Broussais and Universite Pierre et Marie Curie, Paris, France. sebastien.lacroix@brs.ap-hop-paris.fr

Autoimmunity Reviews
|July 10, 2003
PubMed
Summary

Natural and disease-associated anti-Factor VIII (FVIII) antibodies offer insights into autoimmunity. Studies suggest FVIII inhibitors in patients comprise two antibody populations, some resembling natural antibodies and others arising from clonal expansion and mutation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unleashing the prospects of nanomaterials in the treatment of autoimmune and inflammatory diseases.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Decoding disease and therapy through multiomics integration and systems analysis.

Briefings in bioinformatics·2026
Same author

CAR-dendritic cells rewire cardiac immunity for tissue repair.

Cellular & molecular immunology·2026
Same author

Carbohydrate fatty acid monosulphate ester adjuvant enhances the immunogenicity of influenza antigens <i>via</i> TLR4/2-dependent mechanisms.

Frontiers in immunology·2026
Same author

Solving the mystery of vaccine-induced immune thrombocytopenia and thrombosis.

Nature reviews. Cardiology·2026
Same author

High prevalence of bancroftian filariasis and comorbidities in the eastern coalfield regions of West Bengal, India following COVID-19 disruption.

Scientific reports·2026

Area of Science:

  • Immunology
  • Autoimmunity
  • Protein antigen research

Background:

  • Anti-Factor VIII (FVIII) antibodies serve as a model for studying natural autoreactivity versus disease-associated autoimmunity.
  • Both healthy individuals and patients with autoimmune disease possess antibodies targeting FVIII.

Purpose of the Study:

  • To investigate the relationship between natural autoreactivity and disease-associated anti-FVIII antibodies.
  • To understand the origins and characteristics of FVIII inhibitors in autoimmune patients.

Main Methods:

  • Comparative analysis of isotypic distribution and epitope mapping of anti-FVIII antibodies.
  • Studies utilizing cross-reacting idiotypes to differentiate antibody populations.
  • Analysis of B lymphocyte behavior, including clonal expansion and V-region mutation.

Related Experiment Videos

Main Results:

  • Natural and disease-associated anti-FVIII antibodies are difficult to distinguish by isotype or epitope mapping.
  • FVIII inhibitors in patients likely consist of two antibody populations: those similar to natural antibodies and those resulting from affinity maturation and hypermutation.
  • Evidence suggests some inhibitors originate from pre-existing B cell populations expanded upon FVIII exposure.

Conclusions:

  • Anti-FVIII antibodies provide a unique system for studying the spectrum of autoreactivity.
  • FVIII inhibitors in autoimmune disease likely arise from distinct B cell pathways.
  • Understanding these antibody populations has implications for treating autoimmune patients with FVIII inhibitors.